Abstract
The extracellular accumulation of insoluble fibrillar peptides in brain parenchyma and vessel walls as amyloid is the hallmark of neurodegenerative diseases, such as Alzheimer’s disease and Prion diseases. Regardless their amino acid sequences, all amyloid peptides adopt an insoluble, highly ordered beta sheet structure when aggregated. Amyloid is homogeneous and eosinophilic and, common to most cross-beta-type structures; it is generally identified by apple-green birefringence when stained with Congo red and seen under polarized light. Amyloid can also be identified by an apple green color when stained with thioflavine-S and seen under a fluorescence microscope. By electron microscopy, the typical fibrillar ultrastructure of amyloid deposits is revealed. The biochemical nature of the amyloid subunits present in the deposits can be recognized by immunohistochemistry using specific antibodies or by amino acid sequencing analysis, western blot, and mass spectrometry after isolation of parenchymal or vascular amyloid proteins.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Pepys, M.B. (2006) Amyloidosis. Annu. Rev. Med. 57, 223–241.
Prelli, F., Castaño, E.M., Glenner, G.G., and Frangione, B. (1988) Differences between vascular and plaque core amyloid in Alzheimer’s disease, J. Neurochem. 51, 648–651.
Vidal, R., Calero, M., Piccardo, P., Farlow, M.R., Unverzagt, F.W., Mendez, E., Jimenez-Huete, A., Beavis, R., Gallo, G., Gomez-Tortosa, E., Ghiso, J., Hyman, B.T., Frangione, B., and Ghetti, B. (2000) Senile dementia associated with amyloid beta protein angiopathy and tau perivascular pathology but not neuritic plaques in patients homozygous for the APOE-epsilon4 allele, Acta Neuropathol. (Berl.) 100, 1–12.
Vidal, R., Ghiso, J., and Frangione, B. (2000) New familial forms of cerebral amyloid and dementia. Mol Psychiatry. 5(6), 575–576.
Ghetti, B., Tagliavini, F., Masters, C.L., Beyreuther, K., Giaccone, G.,Verga, L., Farlow, M.R., Conneally, P.M., Dlouhy, S.R., Azzarelli, B., and Bugiani, O. (1989) Gerstmann-Sträussler-Scheinker disease. II. Neurofibrillary tangles and plaques with PrP-amyloid coexist in an affected family. Neurology 39,1453–1461.
Vidal, R., Frangione, B., Rostagno, A., Mead, S., Revesz, T., Plant, G., and Ghiso, J. (1999) A stop-codon mutation in the BRI gene associated with familial British dementia. Nature 399, 776–781.
Vidal, R., Revesz, T., Rostagno, A., Kim, E., Holton, J.L., Bek, T., Bojsen-Moller, M., Braendgaard, H., Plant, G., Ghiso, J., and Frangione, B. (2000) A decamer duplication in the 3’ region of the BRI gene originates an amyloid peptide that is associated with dementia in a Danish kindred. Proc Natl Acad Sci USA 97, 4920–4925.
Vidal, R., Ghiso, J., and Frangione, B. (2000) New familial forms of cerebral amyloid and dementia. Mol Psychiatry 5, 575–576.
Vidal, R., Delisle, M.B., and Ghetti, B. (2004) Neurodegeneration caused by proteins with an aberrant carboxyl-terminus. J Neuropathol Exp Neurol 63, 787–800.
Vidal, R., Garzuly, F., Budka, H., Lalowski, M., Linke, R.P., Brittig, F., Frangione, B., and Wisniewski, T. (1996) Meningocerebrovascular amyloidosis associated with a novel transthyretin mis-sense mutation at codon 18 (TTRD 18G) Am J Pathol. 148, 361–366.
Vidal, R.G., Ghiso, J., Gallo, G., Cohen, M., Gambetti, P.L., and Frangione, B. (1992) Amyloidoma of the CNS. II. Immunohistochemical and biochemical study. Neurology. 42, 2024–2028.
Westermark, P., Benson, M.D., Buxbaum, J.N., Cohen, A.S., Frangione, B., Ikeda, S., Masters, C.L., Merlini, G., Saraiva, M.J., and Sipe, J.D. (2007) A primer of amyloid nomenclature. Amyloid. 14, 179–183.
Westermark, G.T., Johnson, K.H., and Westermark, P. (1999) Staining methods for identification of amyloid in tissue. Methods Enzymol. 309, 3–25.
Roher, A.E., and Kuo, Y.M. (1999) Isolation of amyloid deposits from brain. Methods Enzymol. 309, 58–67.
Miravalle, L., Calero, M., Takao, M., Roher, A.E., Ghetti, B., and Vidal, R. (2005) Amino-terminally truncated Aβ peptide species are the main component of cotton wool plaques. Biochemistry. 44, 10810–10821.
Liao, L., Cheng, D., Wang, J., Duong, D.M., Losik, T.G., Gearing, M., Rees, H.D., Lah, J.J., Levey, A.I., and Peng, J. (2004) Proteomic characterization of postmortem amyloid plaques isolated by laser capture microdissection. J Biol Chem. 279, 37061–37068.
Wittliff, J.L.,and Erlander, M.G. (2002) Laser capture microdissection and its applications in genomics and proteomics. Methods Enzymol.356, 12–25.
Cornea, A., Mungenast, A. (2002) Comparison of current equipment. Methods Enzymol. 356, 3–12.
Acknowledgments
We are very grateful to all participants and their families who through their commitment make these studies possible. The authors are grateful to F. Epperson, B. Dupree, and R. Richardson for their technical assistance. This study was supported by grants from the National Institute of Health (NS050227, NS063056, AG10133), the Alzheimer’s association (IIRG-05-14220), and by the American Health Assistance Foundation (A2008-304).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Vidal, R., Ghetti, B. (2011). Characterization of Amyloid Deposits in Neurodegenerative Diseases. In: Manfredi, G., Kawamata, H. (eds) Neurodegeneration. Methods in Molecular Biology, vol 793. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-61779-328-8_16
Download citation
DOI: https://doi.org/10.1007/978-1-61779-328-8_16
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-61779-327-1
Online ISBN: 978-1-61779-328-8
eBook Packages: Springer Protocols